(Q40500253)

English

Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence (English)

1 reference

Europe PubMed Central

21 September 2017

0 references

0 references

Ortrud Monika Barth

5

object named as

Ortrud M Barth

1 reference

Europe PubMed Central

21 September 2017

author name string

Simone M Costa

1

1 reference

Europe PubMed Central

21 September 2017

Marciano V Paes

2

1 reference

Europe PubMed Central

21 September 2017

Débora F Barreto

3

1 reference

Europe PubMed Central

21 September 2017

Angela T Pinhão

4

1 reference

Europe PubMed Central

21 September 2017

João L S Queiroz

6

1 reference

Europe PubMed Central

21 September 2017

Geraldo R G Armôa

7

1 reference

Europe PubMed Central

21 September 2017

Marcos S Freire

8

1 reference

Europe PubMed Central

21 September 2017

Ada M B Alves

9

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

8 August 2005

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

24

1 reference

Europe PubMed Central

21 September 2017

2

1 reference

Europe PubMed Central

21 September 2017

195-205

1 reference

Europe PubMed Central

21 September 2017

Dengue and dengue haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Immunopathogenesis of Dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

The WHO Vaccine Trial Registry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Synergistic Interactions of Anti-NS1 Monoclonal Antibodies Protect Passively Immunized Mice from Lethal Challenge with Dengue 2 Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Update on antiviral DNA vaccine research (1998-2000).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Dengue epidemic in the stage of Rio de Janeiro, Brazil, 1990-1: co-circulation of dengue 1 and dengue 2 serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Circulating human antibodies against dengue NS1 protein: potential of recombinant D2V-NS1 proteins in diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

The use of lead citrate at high pH as an electron-opaque stain in electron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

A comparative study with various anesthetics in mice (pentobarbitone, ketamine-xylazine, carfentanyl-etomidate).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Glycosylation mutants of dengue virus NS1 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Antibody response in mice immunized with a plasmid DNA encoding the colonization factor antigen I of enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Development of a novel mouse model for dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Liver injury and viremia in mice infected with dengue-2 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.059

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.07.059

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40500253&oldid=1899400506"